BACKGROUND: Patients with diabetes mellitus have increased risk of cardiovascular disease; however, there are limited data addressing cardiac rehabilitation in these patients. This study assessed the effectiveness of participation in cardiac rehabilitation on clinical outcomes after myocardial infarction and/or revascularization procedures in diabetic and nondiabetic patients. METHODS: Analysis on 1505 patients completing a minimum of 7 weeks of a 12-week cardiac rehabilitation program included fasting lipid profile and glucose, body mass index, and metabolic equivalent time in patients with diabetes (n = 292) and without diabetes (n = 1213). RESULTS: There were significant improvements in total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) in each group after cardiac rehabilitation. Diabetic women and nondiabetic men had the greatest improvement in HDL-C, with an improvement of 4.9% in diabetic women (P = .02) and an improvement of 4.1% in nondiabetic men (P < or = .0001). On completion of cardiac rehabilitation, both diabetic and nondiabetic patients were at National Cholesterol Education Program Adult Treatment Panel III goals in total cholesterol, LDL-C, HDL-C, and triglycerides at a higher rate. However, patients with diabetes did not reach National Cholesterol Education Program goals for HDL-C, total cholesterol, and triglycerides as effectively as nondiabetic patients. Exercise capacity improved by 28.1% in diabetic patients after cardiac rehabilitation (P < .0001). Improvement in outcomes in the patients with diabetes occurred without significant change in body mass index. CONCLUSIONS: These results suggest that participation in a comprehensive cardiac rehabilitation program integrates care of patients with chronic conditions such as diabetes to achieve comparable cardiac risk factor reduction as achieved with nondiabetic patients.
BACKGROUND:Patients with diabetes mellitus have increased risk of cardiovascular disease; however, there are limited data addressing cardiac rehabilitation in these patients. This study assessed the effectiveness of participation in cardiac rehabilitation on clinical outcomes after myocardial infarction and/or revascularization procedures in diabetic and nondiabeticpatients. METHODS: Analysis on 1505 patients completing a minimum of 7 weeks of a 12-week cardiac rehabilitation program included fasting lipid profile and glucose, body mass index, and metabolic equivalent time in patients with diabetes (n = 292) and without diabetes (n = 1213). RESULTS: There were significant improvements in total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) in each group after cardiac rehabilitation. Diabeticwomen and nondiabeticmen had the greatest improvement in HDL-C, with an improvement of 4.9% in diabeticwomen (P = .02) and an improvement of 4.1% in nondiabeticmen (P < or = .0001). On completion of cardiac rehabilitation, both diabetic and nondiabeticpatients were at National Cholesterol Education Program Adult Treatment Panel III goals in total cholesterol, LDL-C, HDL-C, and triglycerides at a higher rate. However, patients with diabetes did not reach National Cholesterol Education Program goals for HDL-C, total cholesterol, and triglycerides as effectively as nondiabeticpatients. Exercise capacity improved by 28.1% in diabeticpatients after cardiac rehabilitation (P < .0001). Improvement in outcomes in the patients with diabetes occurred without significant change in body mass index. CONCLUSIONS: These results suggest that participation in a comprehensive cardiac rehabilitation program integrates care of patients with chronic conditions such as diabetes to achieve comparable cardiac risk factor reduction as achieved with nondiabeticpatients.
Authors: Marni J Armstrong; Ronald J Sigal; Ross Arena; Trina L Hauer; Leslie D Austford; Sandeep Aggarwal; James A Stone; Billie-Jean Martin Journal: Diabetologia Date: 2015-01-26 Impact factor: 10.122
Authors: Deepika R Laddu; Cemal Ozemek; Trina L Hauer; Codie R Rouleau; Tavis S Campbell; Stephen B Wilton; Sandeep Aggarwal; Leslie Austford; Ross Arena Journal: Int J Cardiol Date: 2019-11-26 Impact factor: 4.164
Authors: Birgitte Bitsch Gadager; Lars Hermann Tang; Maiken Bay Ravn; Patrick Doherty; Alexander Harrison; Jan Christensen; Rod S Taylor; Ann-Dorthe Zwisler; Thomas Maribo Journal: BMC Cardiovasc Disord Date: 2022-06-27 Impact factor: 2.174